Provided by Tiger Trade Technology Pte. Ltd.

BIODLINK-B

5.270
+0.1903.74%
Volume:1.63M
Turnover:8.77M
Market Cap:4.07B
PE:-33.51
High:5.530
Open:5.180
Low:5.180
Close:5.080
52wk High:5.830
52wk Low:1.520
Shares:773.00M
HK Float Shares:772.79M
Volume Ratio:0.72
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.157
ROE:-14.81%
ROA:-3.62%
PB:5.73
PE(LYR):-33.51
PS:4.80

Loading ...

Stock Track | BIODLINK-B Soars 11.09% Intraday as WUXI XDC Takeover Becomes Effective

Stock Track
·
Mar 20

BIODLINK-B Surges Over 11% Again, Shares Double This Year as WUXI XDC Takeover Becomes Effective

Stock News
·
Mar 20

BioDlink International (SEHK:1875) Small FY 2025 H1 Profit Tests Bearish Loss Narratives

Simply Wall St.
·
Mar 19

BIODLINK-B Surges Over 9% as WUXI XDC's Takeover Offer Becomes Effective

Stock News
·
Mar 19

Corrected-Biodlink International (Not TOT BIOPHARM International) FY Revenue RMB 747.645 Million

THOMSON REUTERS
·
Mar 18

BIODLINK-B Reports Annual Revenue of RMB 748 Million, Highlighting Strategic Shift to CDMO

Stock News
·
Mar 18

TOT BIOPHARM International FY Net Income Attributable RMB -100.4 Million

THOMSON REUTERS
·
Mar 18

WuXi XDC (02268) Gains Control of 60% Voting Rights in BioDlink-B (01875); Voluntary Cash Offers Declared Unconditional

Bulletin Express
·
Mar 17

BIODLINK-B Shares Surge Over 5% in Afternoon Trading as WUXI XDC Acquisition Deadline Extended

Stock News
·
Mar 17

BIODLINK-B (01875) Announces February 2026 Monthly Return on Movements in Securities

Bulletin Express
·
Mar 05

BIODLINK-B (01875) Schedules Board Meeting on 18 March 2026 to Review Annual Results

Bulletin Express
·
Mar 05

BioDlink International to Hold Board Meeting to Approve Full-Year Results

Reuters
·
Mar 05

BioDlink International Swings to 2025 Loss

MT Newswires Live
·
Mar 03

BIODLINK-B Reports 2025 Revenue of Approximately RMB 748 Million

Stock News
·
Mar 03

BioDlink International Company Limited (1875), Wuxi Biologics, and the Offeror Issue Clarification on Share Options Under Rule 3.8

Bulletin Express
·
Mar 03

BioDlink International (1875) Announces Unaudited 2025 Financial Results

Bulletin Express
·
Mar 03

TOT BioPharm FY2025 revenue RMB747.6 million

Reuters
·
Mar 03

TOT BIOPHARM Clarifies Outstanding Share Options Total at 7,632,600

Reuters
·
Mar 03

BIODLINK-B (01875) Announces Vesting of 142,000 Share Options

Stock News
·
Mar 01

BioDlink International (1875) Announces Update on Relevant Securities and Takeovers Code Disclosure

Bulletin Express
·
Mar 01